Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |